CAS 1164462-05-8

TG4-155

CAS : 1164462-05-8

Formule : C₂₃H₂₆N₂O₄

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 394.4635

Ref: IN-DA0097AA

TG4-155

CAS : 1164462-05-8

TG4-155

Degré de pureté : ≥95%

Masse moléculaire : 394.46g/mol

Ref: 54-BUP04906

TG4-155

CAS : 1164462-05-8

TG4-155: brain-penetrant EP2 inhibitor, KB 2.4 nM; >1000x weaker at EP4, KB 11.4 μM; selective over other receptors/channels.

Formule : C₂₃H₂₆N₂O₄

Degré de pureté : 97.2%

Couleur et forme : Solid

Masse moléculaire : 394.46

Ref: TM-T5482

TG4-155

Produit contrôlé

CAS : 1164462-05-8

Formule : C₂₃H₂₆N₂O₄

Couleur et forme : Neat

Masse moléculaire : 394.46

Ref: TR-T337940

TG4-155

CAS : 1164462-05-8

TG4-155 is a low potency antiplatelet drug that is a selective antagonist for the prostacyclin receptor. It was initially developed to treat cancer, as it inhibits tumor growth and induces apoptosis in cancer cells. TG4-155 has been shown to be effective in vivo models of breast, prostate, and colon cancers. TG4-155 was also shown to reduce platelet aggregation in primary cells from ovaries and other tissues.

Formule : C₂₃H₂₆N₂O₄

Degré de pureté : Min. 95%

Masse moléculaire : 394.46 g/mol

Ref: 3D-PWB46205